Total Payments
$842.58
2024 Payments
$23.67
Companies
14
Transactions
47
Medicare Patients
1,291
Medicare Billing
$103,325
Payment Breakdown by Category
Food & Beverage$842.58 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $842.58 | 47 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $154.22 | 6 | $0 (2024) |
| ABBVIE INC. | $134.60 | 7 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $100.62 | 6 | $0 (2021) |
| Novo Nordisk Inc | $80.56 | 5 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $73.50 | 5 | $0 (2021) |
| PFIZER INC. | $66.32 | 4 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $48.80 | 4 | $0 (2021) |
| Amgen Inc. | $47.51 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $38.24 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.96 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.67 | 1 | Boston Scientific Corporation ($23.67) |
| 2023 | $95.64 | 3 | Boston Scientific Corporation ($95.64) |
| 2022 | $37.83 | 2 | Boston Scientific Corporation ($19.10) |
| 2021 | $685.44 | 41 | AbbVie Inc. ($115.87) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/27/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/21/2023 | Boston Scientific Corporation | CoverEdge 32 (Device) | Food and Beverage | In-kind items and services | $48.30 | General |
| Category: CoverEdge_NMD | ||||||
| 02/10/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: General - Pain Management_NMD | ||||||
| 01/20/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/12/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: General - Pain Management_NMD | ||||||
| 02/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.77 | General |
| 12/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Neuroscience | ||||||
| 11/12/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: VACCINE | ||||||
| 11/09/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Diabetes | ||||||
| 11/05/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Respiratory | ||||||
| 10/29/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes | ||||||
| 10/08/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2021 | Alfasigma USA, Inc. | — | Food and Beverage | In-kind items and services | $18.88 | General |
| 08/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: PRIMARY CARE | ||||||
| 07/30/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: PRIMARY CARE | ||||||
| 07/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: PRIMARY CARE | ||||||
| 06/29/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, JANUMET | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Bone Health | ||||||
| 06/11/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 424 | 567 | $110,424 | $34,158 |
| 2022 | 5 | 164 | 193 | $29,478 | $5,935 |
| 2021 | 12 | 703 | 901 | $123,219 | $63,232 |
Total Patients
1,291
Total Services
1,661
Medicare Billing
$103,325
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 125 | 125 | $44,625 | $10,218 | 22.9% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 70 | 72 | $14,400 | $9,954 | 69.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 81 | $22,526 | $6,109 | 27.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $13,717 | $3,828 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 24 | $9,438 | $2,627 | 27.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 40 | 44 | $3,168 | $857.22 | 27.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 40 | $1,600 | $344.26 | 21.5% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 22 | 26 | $520.00 | $123.86 | 23.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 26 | $130.00 | $57.20 | 44.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 17 | 100 | $300.00 | $38.49 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 106 | $17,889 | $3,516 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $9,480 | $1,888 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 15 | $1,779 | $415.66 | 23.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 27 | 28 | $196.00 | $84.00 | 42.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 14 | $134.00 | $31.20 | 23.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 256 | 442 | $70,551 | $35,884 | 50.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 81 | 81 | $16,281 | $8,793 | 54.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 86 | 86 | $8,428 | $5,888 | 69.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 67 | $7,169 | $3,652 | 50.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 16 | 17 | $5,355 | $3,104 | 58.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $6,552 | $2,640 | 40.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 12 | $2,520 | $1,312 | 52.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 82 | 82 | $4,100 | $1,239 | 30.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 23 | 26 | $1,040 | $240.24 | 23.1% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 11 | 11 | $385.00 | $225.83 | 58.7% |
About William Caplin
William Caplin is a Nurse Practitioner healthcare provider based in Santa Clara, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2018. The National Provider Identifier (NPI) number assigned to this provider is 1801393236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, William Caplin has received a total of $842.58 in payments from pharmaceutical and medical device companies, with $23.67 received in 2024. These payments were reported across 47 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($842.58).
As a Medicare-enrolled provider, Caplin has provided services to 1,291 Medicare beneficiaries, totaling 1,661 services with total Medicare billing of $103,325. Data is available for 3 years (2021–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Santa Clara, UT
- Active Since 04/11/2018
- Last Updated 01/22/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801393236
Products in Payments
- NURTEC ODT (Drug) $100.62
- VRAYLAR (Drug) $96.92
- Ozempic (Drug) $66.92
- COLOGUARD DNA CAPTURE REAGENTS (Device) $66.32
- BELSOMRA (Drug) $59.21
- CoverEdge 32 (Device) $48.30
- Aimovig (Biological) $25.54
- BREZTRI (Drug) $24.41
- FARXIGA (Drug) $24.39
- UBRELVY (Drug) $23.78
- EVENITY (Biological) $21.97
- SPRAVATO (Drug) $21.75
- General - Pain Management (Device) $19.10
- JARDIANCE (Drug) $18.19
- Vascepa (Drug) $16.92
- XARELTO (Drug) $16.49
- WATCHMAN (Device) $15.81
- GARDASIL 9 (Biological) $14.29
- Tirosint (Drug) $14.11
- SYNTHROID (Drug) $13.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Santa Clara
Debbie Shih, Np, NP
Nurse Practitioner — Payments: $248.82
Nurse Practitioner $248.82
Soo Jung
Nurse Practitioner — Payments: $208.89
Nurse Practitioner $208.89
Brandon Thomas, Np-C, NP-C
Nurse Practitioner — Payments: $168.93
Nurse Practitioner $168.93
Ms. Lily Lu, Np, NP
Nurse Practitioner
Nurse Practitioner
Mrs. Christine Zamora, Fnp, FNP
Nurse Practitioner
Nurse Practitioner
Miss. Jillian Dahlin, Np, NP
Nurse Practitioner
Nurse Practitioner